Our findings indicated that TGF-β/Smad4 signaling was able to repress the HPSE expression in two non-MYCN amplified NB cells (SK-N-SH and SH-SY5Y), but not in MYCN amplified ones. The gene discussed is TGFB1; the disease is neuroblastoma.